Abstract
Nearly one in ten people over the age of 70 have Alzheimer's disease dementia, shows a first-of-its-kind study that paired blood-based markers and clinical assessments to study the disease in Norway. That prevalence is in line with previous estimates for some other white populations. But there were also unexpected differences, including higher disease rates than anticipated in individuals older than 85. "This is very important work from a beautiful Norwegian study," says Nicolas Villain, a neurologist at Sorbonne University in Paris who was not involved in the research. The study, published last month in Nature, shows that blood-based tools can improve epidemiolog-ical estimates of neurodegenerative disease.
NETL
NSTL